Inactive Instrument

Highlights InspireMD Inc Nyse

Equities

US45779A3095

End-of-day quote Nyse Other stock markets
- ^USD	-

03-06	Transcript : InspireMD, Inc., Q4 2023 Earnings Call, Mar 06, 2024
03-06	Earnings Flash (NSPR) INSPIREMD Posts Q4 Revenue $1.8M	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Earnings Flash (NSPR) INSPIREMD Posts Q4 Revenue $1.8M	03-06	MT
InspireMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-05	CI
InspireMD Gets CE Mark Recertification From the European Union	01-31	MT
InspireMD Announces Strategic Agreement with Jacobs Institute to Execute Early Feasibility Study of CGuard EPS for the Treatment of Acute Stroke Patients with Tandem Lesions	11-27	CI
Earnings Flash (NSPR) INSPIREMD Reports Q3 Revenue $1.6M	11-06	MT
InspireMD, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-06	CI
Inspiremd, Inc. Presents Positive 30-Day Follow-Up Results from the C-Guard®? U.S. Investigational Device Exemption Clinical Trial	11-01	CI
InspireMD, Inc. Supports CMS? Final National Coverage Determination Expanding Coverage of Carotid Stenting to Include Both Asymptomatic and Standard Risk Patients	12/10/23	CI
Earnings Flash (NSPR) INSPIREMD Reports Q2 Revenue $1.6M	08/08/23	MT
InspireMD, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	07/08/23	CI
InspireMD, Inc. Announces Completion of Enrollment in C-Guardians U.S. Investigational Device Exemption Clinical Trial	26/06/23	CI
Earnings Flash (NSPR) INSPIREMD Posts Q1 Revenue $1.2M, vs. Street Est of $1.5M	16/05/23	MT
InspireMD, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
InspireMD, Inc. Announces Successful First-In-Human Procedure Utilizing CGuard Prime, its Next Generation Carotid Artery Stent Platform	01/05/23	CI
InspireMD, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	30/03/23	CI
InspireMD, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	30/03/23	CI
Earnings Flash (NSPR) INSPIREMD Posts Q4 Revenue $1M, vs. Street Est of $1M	30/03/23	MT
Earnings Flash (NSPR) INSPIREMD Posts Q3 Revenue $1.4M, vs. Street Est of $1.6M	08/11/22	MT
InspireMD, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	07/11/22	CI
InspireMD, NAMSA Enter Into Outsourcing Partnership	08/09/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights InspireMD Inc Nyse

Equities

US45779A3095

Highlights

Filters